Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker BCAT
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 5.11M | 4.9% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 5.11M | 4.9% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 5.11M | 4.9% | SCHEDULE 13D/A ↗ |
| Jul 28, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 5.35M | 5.1% | SCHEDULE 13D/A ↗ |
| Jul 28, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 5.35M | 5.1% | SCHEDULE 13D/A ↗ |
| Jul 28, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 5.35M | 5.1% | SCHEDULE 13D/A ↗ |
| Jul 14, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 6.62M | 6.3% | SCHEDULE 13D/A ↗ |
| Jul 14, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 6.62M | 6.3% | SCHEDULE 13D/A ↗ |
| Jul 14, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 6.62M | 6.3% | SCHEDULE 13D/A ↗ |
| Jun 30, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 7.80M | 7.5% | SCHEDULE 13D/A ↗ |
| Jun 30, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 7.80M | 7.5% | SCHEDULE 13D/A ↗ |
| Jun 30, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 7.80M | 7.5% | SCHEDULE 13D/A ↗ |
| Jun 11, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 9.02M | 8.6% | SCHEDULE 13D/A ↗ |
| Jun 11, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 9.02M | 8.6% | SCHEDULE 13D/A ↗ |
| Jun 11, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 9.02M | 8.6% | SCHEDULE 13D/A ↗ |
| May 30, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 10.10M | 9.6% | SCHEDULE 13D/A ↗ |
| May 30, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 10.10M | 9.6% | SCHEDULE 13D/A ↗ |
| May 30, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 10.10M | 9.6% | SCHEDULE 13D/A ↗ |
| May 9, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 11.15M | 10.6% | SCHEDULE 13D/A ↗ |
| May 9, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 11.15M | 10.6% | SCHEDULE 13D/A ↗ |
| May 9, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 11.15M | 10.6% | SCHEDULE 13D/A ↗ |
| Mar 3, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 12.54M | 11.7% | SCHEDULE 13D/A ↗ |
| Mar 3, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 12.54M | 11.7% | SCHEDULE 13D/A ↗ |
| Mar 3, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 12.54M | 11.7% | SCHEDULE 13D/A ↗ |
| Jan 21, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management GP, LLC | 13.62M | 12.7% | SCHEDULE 13D/A ↗ |
| Jan 21, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Boaz R. Weinstein | 13.62M | 12.7% | SCHEDULE 13D/A ↗ |
| Jan 21, 2025 | SCHEDULE 13D/A (amended) | BCAT BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 13.62M | 12.7% | SCHEDULE 13D/A ↗ |
27 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:22 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances